A Gwinnett County police officer was fatally shot and his partner seriously wounded Sunday while questioning a suspect in a hotel room near Stone Mountain. The gunman, who had an active warrant, invited the officers inside before opening fire.
The third-quarter earnings season revealed a stark divergence in performance among leading healthcare technology providers. While Omnicell impressed with strong results and a soaring stock, peers like Evolent Health and Astrana Health faced significant market headwinds despite revenue beats.
The construction and maintenance services industry delivered a robust third quarter, with several key players exceeding revenue expectations despite economic headwinds. MYR Group and Comfort Systems stood out with strong beats, while the sector overall demonstrated pricing power and steady demand.
A sharp supply crunch is driving contract prices for mainstream DRAM memory chips up by as much as 95% quarter-on-quarter in early 2025, according to a revised forecast from market analyst TrendForce.
A Beijing court has sentenced ex-Justice Minister Tang Yijun to life imprisonment on bribery charges, state media reported Monday, marking one of the highest-profile convictions in China's ongoing anti-corruption campaign.
The Austrian government has granted a two-year renewal for the Wolfsberg lithium mining license, with a final decision on production expected by end-2026 as lithium prices rebound strongly.
Portland Mayor Keith Wilson has called for U.S. Immigration and Customs Enforcement (ICE) to leave the city, condemning federal agents' deployment of tear gas and other crowd-control munitions against a weekend protest he described as peaceful.
Roth Capital has upgraded Energy Fuels (UUUU) from 'Sell' to 'Neutral', raising its price target to $15. The move follows the uranium miner's strategic acquisition of Australian Strategic Materials, expanding its rare earths portfolio and positioning within Western critical mineral supply chains.
Chevron's fourth-quarter profit fell 12.5% year-over-year, pressured by lower oil prices, but the energy giant highlighted robust operational cash flow, record production levels following its Hess acquisition, and significant progress in its long-term strategic projects.
The Hong Kong Monetary Authority (HKMA) is poised to grant its inaugural stablecoin issuer licenses in March, with approvals expected for only a select few firms. The move transitions the city's digital asset framework from sandbox testing to a formally regulated market, focusing on stringent risk controls and credible use cases.
Recent data shows the average Bitcoin held by U.S. spot ETFs is now worth less than its purchase price, following two consecutive weeks of major outflows that have deepened the cryptocurrency's downturn.
After years of relentless growth, a cooling trend is taking hold in several Western U.S. housing markets. We examine the metros where prices are falling, what's driving the change, and how prospective buyers can navigate this shifting landscape.
Boston Scientific's latest earnings beat and raised guidance, fueled by strong demand for its electrophysiology devices, signal a strategic shift. The company is navigating tariff pressures while expanding margins, with major acquisitions poised to reshape its long-term profile.
A fresh price target for Euronext Brussels-listed IT services firm Econocom Group has analysts and investors reassessing the company's trajectory. The update reflects evolving views on the company's strategic positioning and market conditions.
Lucky Strike Entertainment's stock has tumbled nearly 24% over the past year, raising critical questions about its true worth. We analyze whether the current price reflects underlying value or signals an overextended valuation.
French IT giant Capgemini moves to sell its U.S. government solutions subsidiary following political and internal pressure over its contract with Immigration and Customs Enforcement (ICE), as public debate intensifies around tech's role in immigration enforcement.
Takeda Pharmaceutical's (TSE:4502) recent share price rally has ignited a debate among investors. With the stock closing at ¥5,242, analysts are divided on its true worth, presenting a complex picture of fair value signals and future growth prospects.
IDEAYA Biosciences shares have retreated from recent highs, presenting investors with a dilemma. While long-term performance remains strong, its premium valuation and significant net losses raise questions about whether the current price already reflects its promising pipeline.
A five-year-old boy and his father have been released from immigration detention after a federal judge sharply criticized ICE's tactics, accusing the agency of a 'perfidious lust for unbridled power' in a case that has ignited national outrage.
Global markets stumbled on Monday, with Asian shares and U.S. futures declining sharply. The sell-off was led by a significant pullback in South Korean tech stocks amid renewed concerns over an AI sector bubble, while oil prices dropped over $2 per barrel.
